[email protected]
Research paper published by the Actinogen team diving into the current literature on 11BHSD1 inhibition. They describe some potential future indications for Xanamem but nothing conclusive - the science is still quite unclear on this one unfortunately.
- Forums
- ASX - By Stock
- ACW
- 11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
ACW
actinogen medical limited
Add to My Watchlist
0.00%
!
2.6¢

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.60M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $22.66K | 897.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 522475 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 650495 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 522475 | 0.025 |
10 | 1955275 | 0.024 |
13 | 2039283 | 0.023 |
16 | 3043035 | 0.022 |
11 | 7195768 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 650495 | 6 |
0.027 | 1615676 | 6 |
0.028 | 630042 | 7 |
0.029 | 1778142 | 6 |
0.030 | 1751961 | 10 |
Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |